# the product.

In 2007, the FDA made a seemingly minor procedural change to the

way its AdComs operated. Prior to the change, post-discussion voting

was typically conducted in a sequential manner: each committee

member would visibly and audibly cast their vote and explain their

position in turn, one after the other. After the change, voting was to be